SOX2 and prostate carcinoma: Our analysis of 22Rv1 stem/progenitor cell marker gene expression revealed a small increase in NANOG and reduction in SOX2 in GSK-3α-silenced cells (Figure 1E), inconsistent with selection for prostate cancer stem/progenitor-like cells.